Masitinib CAS 790299-79-5
Masitinib est tyrosine kinase inhibitor. Eius indicia clinica sunt sclerosis amyotrophica lateralis, mastocytosis, cancer pancreaticus, multiplex sclerosis, asthma, cancer prostatae etc.
Item | Specification |
MW | 498.64 |
Densitas | 1.280±0.06 g/cm3(Praedicta) |
EINECS | 226-164-5 . |
pKa | 13.24±0.70 (Praedicta) |
punctum liquescens | 90-95°C |
Repono conditionibus | leo |
Masitinib, notum est mesatinib, mesylatum, est factoris alpha/betae receptoris tyrosini kinasi inhibitoris inhibitoris mesatinib evolutae ab Scientia AB curatione multiplex myeloma, tumores gastrointestinalium stromalium et cancer prostatae.
Solet in 25kg/orum referta, et sarcina nativus facere potest.
Masitinib CAS 790299-79-5
Masitinib CAS 790299-79-5
Epistulam tuam hic scribe et mitte nobis